Details of issuance or disposal
Issuance of new shares and the 14th and 15th Series Stock Acquisition Rights through a third-party allotment (payment completed)
12,000,000 new shares; 38,000,000 potential shares underlying the 14th Series Stock Acquisition Rights; and 45,000,000 potential shares underlying the 15th Series Stock Acquisition Rights
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
New shares: ¥108,000,000; 14th Series Stock Acquisition Rights: ¥3,800; 15th Series Stock Acquisition Rights: ¥4,500
Total potential shares: 83,000,000. The ratio to the total number of issued shares (45,685,080 shares after the issuance of these new shares) is not disclosed
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of new shares and the 14th and 15th Series Stock Acquisition Rights through a third-party allotment (payment completed) |
| Number of shares to be issued or disposed of | 12,000,000 new shares; 38,000,000 potential shares underlying the 14th Series Stock Acquisition Rights; and 45,000,000 potential shares underlying the 15th Series Stock Acquisition Rights |
| Issue price and disposal price | New shares: ¥9 per share; 14th Series Stock Acquisition Rights: ¥0.01 per right; 15th Series Stock Acquisition Rights: ¥0.01 per right |
| Total issue value | New shares: ¥108,000,000; 14th Series Stock Acquisition Rights: ¥3,800; 15th Series Stock Acquisition Rights: ¥4,500 |
| Amount of funds to be raised | New shares: ¥102,415,615; 14th Series Stock Acquisition Rights: ¥336,419,415; 15th Series Stock Acquisition Rights: ¥399,420,115 |
| Estimated issuance expenses | not disclosed (each amount of funds raised is after deducting one-third of the estimated issuance expenses) |
| Payment date | 30 March 2026 |
| Intended allottee | Name SAMURAI JAPAN INVESTMENTS PTE. LTD / Number of Shares 12,000,000 shares, Name EVO FUND / Number of Shares 380,000 14th Series Stock Acquisition Rights (38,000,000 potential shares), Name KJ Equity Partners Co.,Ltd. / Number of Shares 450,000 15th Series Stock Acquisition Rights (45,000,000 potential shares) |
| Dilution Rate | Total potential shares: 83,000,000. The ratio to the total number of issued shares (45,685,080 shares after the issuance of these new shares) is not disclosed |
| Total number of issued shares | 33,685,080 shares → 45,685,080 shares |
| Exercise price | ¥9 per share for both the 14th and 15th Series Stock Acquisition Rights. The disclosure states that the amount of funds raised may increase or decrease if the exercise price is adjusted, but the details and floor of the adjustment provision are not disclosed |
| Exercise period | 14th Series: from 31 March 2026 to 31 March 2027; 15th Series: from 31 March 2026 to 30 March 2029 |
| Number of Stock Acquisition Rights | 14th Series: total issued, 380,000 rights; remaining unexercised rights, not disclosed. 15th Series: total issued, 450,000 rights; remaining unexercised rights, not disclosed |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price by each allottee for the issuance resolved at the meeting of the Board of Directors held on 26 February 2026 has been completed.